{
  "url_to_unified_index": {
    "https://cloudlims.com/overcome-barriers-in-covid-19-point-of-care-diagnostics/": 2,
    "https://pmc.ncbi.nlm.nih.gov/articles/PMC7594747/": 1,
    "https://www.nature.com/articles/s41598-021-01655-y": 3
  },
  "url_to_info": {
    "https://cloudlims.com/overcome-barriers-in-covid-19-point-of-care-diagnostics/": {
      "url": "https://cloudlims.com/overcome-barriers-in-covid-19-point-of-care-diagnostics/",
      "description": "27 Oct 2021 \u2014 Given the limited testing resources, such a massive scale of testing has been hard to achieve. Point-of-care testing (POCT) can help accelerate ...",
      "snippets": [
        "27 Oct 2021 \u2014 Given the limited testing resources, such a massive scale of testing has been hard to achieve. Point-of-care testing (POCT) can help accelerate ..."
      ],
      "title": "Overcome Barriers in COVID-19 Point-of-care Diagnostics",
      "meta": {
        "query": "barriers to accessibility of covid 19 point of care diagnostics"
      },
      "citation_uuid": -1
    },
    "https://pmc.ncbi.nlm.nih.gov/articles/PMC7594747/": {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7594747/",
      "description": "by K Munir \u00b7 2020 \u00b7 Cited by 77 \u2014 SARS-CoV-2 is a zoonotic disease that has crossed species barrier from its reservoir bat host, and infected humans via an unknown intermediate animal species.",
      "snippets": [
        "by K Munir \u00b7 2020 \u00b7 Cited by 77 \u2014 SARS-CoV-2 is a zoonotic disease that has crossed species barrier from its reservoir bat host, and infected humans via an unknown intermediate animal species."
      ],
      "title": "Zoonotic and reverse zoonotic events of SARS-CoV-2 and ...",
      "meta": {
        "query": "sars cov 2 zoonotic transmission"
      },
      "citation_uuid": -1
    },
    "https://www.nature.com/articles/s41598-021-01655-y": {
      "url": "https://www.nature.com/articles/s41598-021-01655-y",
      "description": "by MR Rahbar \u00b7 2021 \u00b7 Cited by 14 \u2014 Our focus on three hotspots of RBM, namely F486SARS-CoV-2, Q493SARS-CoV-2, and N501SARS-CoV-2, surmises the overall conserved physicochemical ...",
      "snippets": [
        "by MR Rahbar \u00b7 2021 \u00b7 Cited by 14 \u2014 Our focus on three hotspots of RBM, namely F486SARS-CoV-2, Q493SARS-CoV-2, and N501SARS-CoV-2, surmises the overall conserved physicochemical ..."
      ],
      "title": "Hotspots for mutations in the SARS-CoV-2 spike glycoprotein",
      "meta": {
        "query": "Current SARSCoV2 hotspots"
      },
      "citation_uuid": -1
    }
  }
}